Led by Mac Davis, Minicircle is developing an innovative gene therapy platform that uses DNA plasmids to add genes to the human body without altering the existing genome. This reversible, non-inflammatory, and non-heritable approach aims to make gene therapy fast, safe, and accessible. Currently, Minicircle is conducting clinical trials in Roatan, Caribbean, to validate this advanced therapy, which could revolutionize health and disease prevention.